Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Diagnostics Unit Teams Up With Big Pharma On Companion Test

This article was originally published in The Gray Sheet

Executive Summary

Abbott's molecular diagnostics business announced March 7 a collaboration with Genentech, Roche and OSI Pharmaceuticals to develop a gene test that helps select patients more likely to respond to the lung cancer drug Tarceva
Advertisement

Related Content

Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response
Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response
People In Brief
Diagnostics In Brief
Diagnostics In Brief
Advertisement
UsernamePublicRestriction

Register

MT025849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel